Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Can You Hear Me?’ US FDA Begins Meeting Virtually

Executive Summary

The GDUFA regulatory science priorities virtual meeting runs smoothly, and proves productive, despite glitches.

You may also be interested in...



US FDA May Publish Pre-Recorded Presentations Before Virtual Advisory Committee Meetings

The move is intended to streamline virtual advisory committee meetings, FDA official says.

Going Virtual: GSK’s Multiple Myeloma Drug Belantamab Tapped For US FDA Online AdComm In July

Announcement of the 14 July Oncologic Drugs Advisory Committee meeting follows a successful, two-day trial run of the virtual format by the oncology pediatric subcommittee that featured a mix of prerecorded and live sponsor presentations and strict adherence to a call/response approach to ensure orderly conduct.

US FDA May Make Pre-Recorded Virtual Adcom Presentations Available Before Meeting

The move is intended to streamline virtual advisory committee meetings, FDA official says.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS142187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel